Overview

Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
This study will determine the efficacy and safety of combination therapy with divalproex and lithium for treating mania in people with rapid cycling bipolar disorder and a substance abuse disorder.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center
Collaborators:
Abbott
National Institute of Mental Health (NIMH)
Treatments:
Lithium Carbonate
Valproic Acid